Cost Of Revenue - Shilpa Medicare Ltd (NSE:SHILPAMED) - Alpha Spread

Shilpa Medicare Ltd
NSE:SHILPAMED

Watchlist Manager
Shilpa Medicare Ltd Logo
Shilpa Medicare Ltd
NSE:SHILPAMED
Watchlist
Price: 802.3 INR -0.42% Market Closed
Market Cap: 78.5B INR
Have any thoughts about
Shilpa Medicare Ltd?
Write Note

Shilpa Medicare Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shilpa Medicare Ltd
Cost of Revenue Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Shilpa Medicare Ltd
NSE:SHILPAMED
Cost of Revenue
-â‚ą4.1B
CAGR 3-Years
-13%
CAGR 5-Years
-11%
CAGR 10-Years
-2%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cost of Revenue
-â‚ą84.5B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cost of Revenue
-â‚ą87.8B
CAGR 3-Years
-4%
CAGR 5-Years
-10%
CAGR 10-Years
-8%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cost of Revenue
-â‚ą105.8B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
-10%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Cost of Revenue
-â‚ą61.4B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-7%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cost of Revenue
-â‚ą27.3B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-8%

See Also

What is Shilpa Medicare Ltd's Cost of Revenue?
Cost of Revenue
-4.1B INR

Based on the financial report for Jun 30, 2024, Shilpa Medicare Ltd's Cost of Revenue amounts to -4.1B INR.

What is Shilpa Medicare Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-2%

Over the last year, the Cost of Revenue growth was -3%. The average annual Cost of Revenue growth rates for Shilpa Medicare Ltd have been -13% over the past three years , -11% over the past five years , and -2% over the past ten years .

Back to Top